Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Status:
Unknown status
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
A Controlled Clinical Study of Endostar/PD-1 Inhibitors Combined With
chemotherapy(Carboplatin-Pemetrexed) as First-line Treatment for Advanced Non-squamous Cell
Lung Cancer With Negative Driving Gene